Formestane Preferred as Second-Line Therapy in Advanced Breast Cancer

    May 1993 in “ Drugs & Therapy Perspectives
    NULL AUTHOR_ID
    Image
    Studysummary Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community โ†’